Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Kala Bio Inc (KALA)

Kala Bio Inc (KALA)
6.50 x 1 7.40 x 5
Pre-market by (Cboe BZX)
6.92 +0.12 (+1.76%) 03/21/25 [NASDAQ]
6.50 x 1 7.40 x 5
Pre-market 6.92 unch (unch) 16:00 ET
Quote Overview for Fri, Mar 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
6.85
Day High
6.98
Open 6.87
Previous Close 6.80 6.80
Volume 22,900 22,900
Avg Vol 20,670 20,670
Stochastic %K 31.03% 31.03%
Weighted Alpha -18.36 -18.36
5-Day Change +0.37 (+5.65%) +0.37 (+5.65%)
52-Week Range 4.21 - 11.20 4.21 - 11.20
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 42,151
  • Shares Outstanding, K 6,091
  • Annual Sales, $ 0 K
  • Annual Income, $ -42,200 K
  • EBIT $ -41 M
  • EBITDA $ -40 M
  • 60-Month Beta -2.19
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.57

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -2.28
  • Number of Estimates 2
  • High Estimate -2.09
  • Low Estimate -2.47
  • Prior Year -3.18
  • Growth Rate Est. (year over year) +28.30%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.39 +8.29%
on 02/24/25
Period Open: 6.64
7.97 -13.15%
on 03/05/25
+0.28 (+4.22%)
since 02/21/25
3-Month
5.80 +19.31%
on 12/23/24
Period Open: 5.92
11.20 -38.21%
on 02/10/25
+1.00 (+16.89%)
since 12/20/24
52-Week
4.21 +64.37%
on 06/26/24
Period Open: 8.00
11.20 -38.21%
on 02/10/25
-1.08 (-13.50%)
since 03/21/24

Most Recent Stories

More News
KALA BIO to Present at TD Cowen 45th Annual Health Care Conference

KALA : 6.92 (+1.76%)
Kala Bio Stock Sinks On CEO Exit, But Retail Feels It’s An Overreaction

Kala is set to report mid-stage trial data in the second quarter for KPI-012, its experimental treatment for persistent corneal epithelial defects.

ITOT : 124.88 (+1.23%)
VXF : 180.37 (+1.78%)
KALA : 6.92 (+1.76%)
VTI : 282.31 (+1.24%)
KALA BIO Announces Chief Executive Officer Transition

KALA : 6.92 (+1.76%)
KALA BIO Announces $10,750,000 Private Placement

KALA : 6.92 (+1.76%)
KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference

KALA : 6.92 (+1.76%)
KALA BIO: Q3 Earnings Snapshot

KALA BIO: Q3 Earnings Snapshot

KALA : 6.92 (+1.76%)
KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update

KALA : 6.92 (+1.76%)
KALA BIO: Q2 Earnings Snapshot

KALA BIO: Q2 Earnings Snapshot

KALA : 6.92 (+1.76%)
Pre-Market Brief: Stocks Rebound As China Reopening Hopes Boost Sentiment

March S&P 500 futures (ESH23) are trending moderately down -0.07% this morning after three major U.S. benchmark indices finished the regular session in the red as new data on the labor market sparked investors’...

ESH23 : 3,957.05s (-0.09%)
SAND.S.DX : 228.800 (+0.13%)
NFLX : 958.18 (-0.22%)
WBD : 10.84 (+0.93%)
KALA : 6.92 (+1.76%)
TMUS : 259.36 (+1.38%)
JWN : 24.33 (-0.08%)
COST : 926.59 (+1.91%)
Here’s Why Sotera Health Company Stock Just Doubled in a Day

Sotera Health Company (NASDAQ: SHC) is a leading global provider of mission-critical sterilization solutions, lab testing, and advisory services.

SHC : 12.04 (+1.18%)
KALA : 6.92 (+1.76%)

Business Summary

KALA BIO is a clinical-stage biopharmaceutical company. It focused on the research, development and commercialization of therapies for rare and severe diseases of the eye. The company' s lead product candidate consists KPI-012. KALA BIO, formerly known as Kala Pharmaceuticals Inc., is based in ARLINGTON,...

See More

Key Turning Points

3rd Resistance Point 7.11
2nd Resistance Point 7.05
1st Resistance Point 6.98
Last Price 6.92
1st Support Level 6.85
2nd Support Level 6.79
3rd Support Level 6.72

See More

52-Week High 11.20
Fibonacci 61.8% 8.53
Fibonacci 50% 7.70
Last Price 6.92
Fibonacci 38.2% 6.88
52-Week Low 4.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals